PG · NYSE
Procter & Gamble is a global consumer-goods company that sells branded products across household, personal-care, beauty, health and related categories. It makes money primarily by selling those products to consumers through retail and other distribution channels. The supplied evidence does not provide a segment revenue breakdown, so the relative contribution of individual categories cannot be quantified. P&G reported fiscal 2026 revenue of $87.0 billion and net income of $16.0 billion, compared with $84.3 billion of revenue and $16.0 billion of net income in fiscal 2025. It is expanding its health-and-wellness presence through the planned $3.8 billion cash acquisition of Thorne.
Procter & Gamble fell $0.87, or 0.58%, over the period, ending at $148.01 after a sharp midweek selloff and partial recovery. The stock dropped from $148.88 to $143.96 across July 29-30, as investors absorbed the company’s fiscal 2027 outlook for core EPS of $6.89-$7.11, implying only 0%-3% growth, alongside flat organic sales and consumer resistance to further pricing. It then recovered on July 31 and August 3-4, including a $3.04 gain on August 4. The announced $3.8 billion cash purchase of Thorne added strategic health-and-wellness expansion but did not prevent the earnings-driven decline. No broader market catalyst was supplied.
Worried About the Market? Hide Out in These 3 High-Yielding Dividend StocksWhy the "Magnificent Seven" Trade Is Starting to Fracture, and Where You Should Invest InsteadSPY, PG, HD, GS: ETF Inflow AlertP&G Guided Below Estimates and Sits 5% Above a 52-Week Low. I'm Not Buying It Yet, and Here's What Would Change That.
